TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Invex Therapeutics Ltd. ( (AU:IXC) ) has shared an update.
Invex Therapeutics Ltd has been suspended from quotation on the ASX due to non-compliance with the Corporations Act 2001, specifically for not having sufficient directors. The suspension will remain until the company meets the ASX’s listing rules, impacting its market operations and requiring resolution to regain trading status.
More about Invex Therapeutics Ltd.
Invex Therapeutics Ltd is a company listed on the Australian Securities Exchange (ASX) and operates in the biotechnology sector. The company focuses on developing therapeutic solutions, although specific products or market focus are not detailed in the provided text.
Average Trading Volume: 67,028
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$8.64M
Find detailed analytics on IXC stock on TipRanks’ Stock Analysis page.